Skip to main content
. 2008 Aug 28;7:16. doi: 10.1186/1744-859X-7-16

Table 5.

Market share of the alternative treatments

Comparators Market share in units (%) Source
Paliperidone ER 0.0 Not yet marketed
Risperidone 42.0 http://www.imshealth.com
Olanzapine 34.4 http://www.imshealth.com
Quetiapine 14.1 http://www.imshealth.com
Ziprasidone 4.7 http://www.imshealth.com
Aripiprazole 4.8 http://www.imshealth.com